Descriptions of Benefits and Risks in Consent Forms for Phase 1 Oncology Trials

Authors:
  • EEEzekiel J. Emanuel
    Ezekiel J. Emanuel
  • BWBenjamin Wilfond
    Benjamin Wilfond
  • JRJonathan Rackoff
    Jonathan Rackoff
  • KMKaren Martz
    Karen Martz

Abstract
Ethicists have suggested that written consent forms encourage participants in phase 1 cancer trials to expect benefit from the experimental agent and to overlook serious risks.

This publication has 20 references indexed in Scilit: